Newton J F, Kuo C H, DeShone G M, Hoefle D, Bernstein J, Hook J B
Toxicol Appl Pharmacol. 1985 Dec;81(3 Pt 1):416-30. doi: 10.1016/0041-008x(85)90413-2.
Acetaminophen (APAP) produces proximal tubular necrosis in Fischer 344 (F344) rats. Recently, p-aminophenol (PAP), a known potent nephrotoxicant, was identified as a metabolite of APAP in F344 rats. The purpose of this study was to determine if PAP formation is a requisite step in APAP-induced nephrotoxicity. Therefore, the effect of bis(p-nitrophenyl) phosphate (BNPP), an acylamidase inhibitor, on APAP and PAP nephrotoxicity and metabolism was determined. BNPP (1 to 8 mM) reduced APAP deacetylation and covalent binding in F344 renal cortical homogenates in a concentration-dependent manner. Pretreatment of animals with BNPP prior to APAP or PAP administration resulted in marked reduction of APAP (900 mg/kg) nephrotoxicity but not PAP nephrotoxicity. This result was not due to altered disposition of either APAP or acetylated metabolites in plasma or renal cortical and hepatic tissue. Rather, BNPP pretreatment reduced the fraction of APAP excreted as PAP by 64 and 75% after APAP doses of 750 and 900 mg/kg. BNPP did not alter the excretion of APAP or any of its non-deacetylated metabolites nor did BNPP alter excretion of PAP or its metabolites after PAP doses of 150 and 300 mg/kg. Therefore, the BNPP-induced reduction in APAP-induced nephrotoxicity appears to be due to inhibition of APAP deacetylation. It is concluded that PAP formation, in vivo, accounts, at least in part, for APAP-induced renal tubular necrosis.
对乙酰氨基酚(APAP)可导致Fischer 344(F344)大鼠近端肾小管坏死。最近,对氨基酚(PAP)这种已知的强效肾毒物被鉴定为F344大鼠体内APAP的一种代谢产物。本研究的目的是确定PAP的形成是否是APAP诱导肾毒性的必要步骤。因此,测定了酰基酰胺酶抑制剂双(对硝基苯基)磷酸酯(BNPP)对APAP和PAP肾毒性及代谢的影响。BNPP(1至8 mM)以浓度依赖的方式降低了F344肾皮质匀浆中APAP的脱乙酰作用和共价结合。在给予APAP或PAP之前用BNPP预处理动物,可显著降低APAP(900 mg/kg)的肾毒性,但不能降低PAP的肾毒性。这一结果并非由于血浆、肾皮质和肝组织中APAP或乙酰化代谢产物的处置发生改变。相反,BNPP预处理使750和900 mg/kg剂量的APAP以PAP形式排泄的比例分别降低了64%和75%。BNPP不改变APAP或其任何未脱乙酰代谢产物的排泄,在给予150和300 mg/kg剂量的PAP后,BNPP也不改变PAP或其代谢产物的排泄。因此,BNPP诱导的APAP诱导肾毒性降低似乎是由于抑制了APAP的脱乙酰作用。得出的结论是,体内PAP的形成至少部分地导致了APAP诱导的肾小管坏死。